Clinical Trial: HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277192) titled 'HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival' on Nov. 13.

Brief Summary: The purpose of this study is to compare the liver injury induced by HAIC combined with PD-1/PD-L1 inhibitors and TKIs versus triple therapy with TACE in the treatment of patients with advanced HCC; to compare the efficacy of the two triple therapy regimens in the treatment of patients with advanced HCC.

Study Start Date: Oct. 01, 2023

Study Type: OBSERVATIONAL

Condition: Hepatecellular Carcinoma Liver Injury HAIC(Hepatic Artery Infusion Chemotherapy) TACE(Transcatheter Arterial C...